Molecular Profiling for Myeloma and Its Precursor Disease

VIDEO | 05:00

Ola Landgren, Chief of the Myeloma Service at Memorial Sloan Kettering, explains how molecular profiling tests are used to analyze the biology of myeloma and personalize a patient’s care. There are many different subtypes of myeloma, all of which behave differently and require different treatment approaches. MSK doctors are refining the molecular profiling tools used to identify these subtypes and using this information to treat patients through clinical trials of new therapies.